Project Grant R43AA032150

Award Date 5/15/25
Completion Date 4/30/26
Dollars Obligated $500K
Federal Grant Program
93.273
Assistance Type
Project Grant
Place of Performance
Alabama, USA
Similar Awards
The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded a $438,375 Project Grant under the Alcohol Research Programs (CFDA 93.273) to Cedars-Sinai Medical Center to establish a human liver-on-a-chip model for studying alcohol-associated liver disease (ALD). The 2-year project, starting September 2023, aims to investigate the roles of liver sinusoidal endothelial cells and acetaldehyde metabolism in regulating ethanol-induced liver damage as well as the contribution of fibrotic...
This $673,500 Project Grant from the National Institutes of Health's National Institute on Alcohol Abuse and Alcoholism will fund Amygdala Neurosciences, Inc. to develop new, potent, selective, and reversible inhibitors of aldehyde dehydrogenase 2 (ALDH2) for the treatment of alcohol use disorder. The goal is to implement an innovative screening technology to discover novel compounds that reduce craving and alcohol consumption by selectively inhibiting ALDH2 in a reversible manner, avoiding...
This federal Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (CFDA 93.273 - Alcohol Research Programs) to Yale University for $366,406.00 will support the development of a novel human laboratory paradigm to screen alcohol use disorder (AUD) medications. The project aims to create two models that can assess an individual's ability to resist drinking and measure heavy drinking behavior, mapping to key FDA endpoints for AUD medication approval and WHO risk...
The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded a $545,282 Project Grant under the Alcohol Research Programs (CFDA 93.273) to the University of Colorado-Denver to study neural mechanisms associated with emotion regulation and alcohol cue reactivity during early abstinence from alcohol use disorder (AUD). The 5-year project aims to determine how neural function related to cognitive reappraisal and alcohol cue processing changes across early AUD treatment, and whether...
The National Institute on Alcohol Abuse and Alcoholism (NIAAA) has awarded a $152,000 Project Grant under the Alcohol Research Programs (CFDA 93.273) to Des Moines University Osteopathic Medical Center (DMU) to study the role of GLUD1 receptors in regulating structural plasticity during chronic ethanol exposure and withdrawal. The two-year grant, awarded on September 1, 2023, will support DMU's research aimed at understanding how GLUD1 receptor function and expression influence dendritic spine...
The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded a $399,048 Project Grant under the Alcohol Research Programs (CFDA 93.273) to the Rochester Institute of Technology (RIT) on September 17, 2024. The grant will fund a study examining behavioral and electrophysiological cue reactivity in young adult binge drinkers versus social drinkers. The study will compare responses to uni- and multi-sensory alcohol and neutral cues varying in degree of realistic appearance, including...
The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded a $146,000 Project Grant under its Alcohol Research Programs (CFDA 93.273) to Louisiana State University Health Sciences Center-Shreveport. This 2-year grant will fund research to examine the impact of chronic alcohol use on acetylcholine signaling in the brain of rhesus macaques. The key objectives are to: 1) refine and validate techniques for measuring acetylcholine release in mouse brain slices, and then 2) use these...
The University of California Irvine was awarded a $412,125 Project Grant from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) federal grant program. The grant funds a research project to comprehensively determine how alcohol consumption alters the metabolism of critical organs, which can contribute to alcohol-induced organ damage. The project will employ arteriovenous metabolomics to quantitatively measure the dynamic metabolic...
The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded a $581,869 Project Grant under the Alcohol Research Programs (CFDA 93.273) to The University of Kentucky Research Foundation. The grant will fund a rigorous 4-year crossover study to translate preclinical findings on the role of glucocorticoid receptors in alcohol use disorder (AUD) to humans. The study will use the selective glucocorticoid receptor antagonist PT150 to examine its effects on stress-induced and alcohol-induced...
This federal Project Grant award of $594,784 from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) will support a study to identify novel transcriptomic and epigenetic changes in biological pathways that may serve as biomarkers and therapeutic targets for alcohol use disorder (AUD). The research team at Yale University will perform a postmortem, multi-omic analysis of brain tissue samples from 341 subjects, including those with AUD,...

The National Institute on Alcohol Abuse and Alcoholism (NIAAA), under the Alcohol Research Programs (CFDA 93.273) federal grant program, awarded a $499,987 Project Grant to CFD Research Corporation. The grant funding will support the development of a High Throughput Alcohol Screening Platform (HT-ASP) that incorporates cortical organoids, which are advanced 3D tissue models representing the human brain. This system will automate the maturation, maintenance, and assaying of over 100 brain organoids simultaneously to enable high-throughput screening of potential therapeutic candidates for treating alcohol use disorder (AUD). The project aims to create a robust and genetically diverse platform for evaluating drug candidates, leveraging the unique capabilities of cortical organoids to model the specific effects of alcohol on the prefrontal cortex, which is a key brain region involved in AUD.

Generated 6/17/25, 3:47 AM